ERBB2 and breast cancer: In our sample, the percentage of HER2 overexpressing tumors was 10.5% in women with PABC, 1% in BC nulliparous patients and 2.3% in BC patients diagnosed beyond 2 years from pregnancy, although in other studies HER2 positive PABC reached 30% [39].